Open original FDA record ↗Recall record
- FDA identifier
- Z-1070-2010
- Company in FDA record
- Medtronic Inc
- FDA classification date
- Mar 11, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Recently the US Food and Drug Administration (FDA) issued an alert, communicating a change in the United States Pharmacopeia (USP) monograph for heparin, introducing a new USP reference standard that will in effect, change potency, and harmonize the USP unit dose with the WHO International Standard (IU) unit dose. Users of the Medtronic Hemostasis Management System (HMS Plus) must be aware o
Source facts
- Action
- Consignees were sent a Medtronic "Urgent Medical Device Notice' dated December 14, 2009. The letter was addressed to "Valued Customer". The letter described the product and the problem. Advised customers to configure the HMS Plus appropriately. The Field Notification was sent to all current HMS Plus users. The current HMS Plus users were identified by the sales of HMS Plus disposable product -Heparin Assay Cartridges from the period of August 1, 2008 to date. This time was considered appropriate, being more than twice the longest expiration date of any of the HMS disposable.
- Initiated
- 2009-12-14
- Root cause
- Other
- Terminated
- 2011-12-24
- Distribution
- All states in USA (Including DC) except RI and VT.
- Recall number
- Z-1070-2010
- Recall status
- Terminated
- CDRH record ID
- 87953
- FDA classified
- 2010-03-11
- Recall event number
- 54251